National

IHIT identify man in homicide case as Jeevan Singh Sull of Abbotsford

Darpan News Desk IHIT, 22 Mar, 2021 12:54 AM

On March 3, 2021 Abbotsford Emergency Services responded to a 911 hang up call in the 32300 block of Slocan Drive. An injured male was located and transported to hospital. The male has since succumbed to his injuries.

IHIT has identified Abbotsford victim as a 61 year old South Asian man in this incident by the name of Jeevan Singh Sull. The twitter post has the details below.

Media availability for this investigation outside Abbotsford Police Department Headquarters at 11:00 a.m. this morning. https://t.co/KI1S5Epont pic.twitter.com/eoBDY0NGil

— IHIT (@HomicideTeam) March 21, 2021

It was an isolated, contained incident and there is no ongoing danger to the community.

Photo courtesy of IHIT via Twitter.

Prev Next

MORE National ARTICLES

Economy fell 5.4 per cent in 2020: StatCan

Statistics Canada says real gross domestic product shrank 5.4 per cent in 2020, the steepest annual decline since comparable data was first recorded in 1961.

Economy fell 5.4 per cent in 2020: StatCan

Vancouver home sales up 73% year-over-year: REBGV

"The supply of listings for sale isn’t keeping up with the demand we’re seeing,” said Colette Gerber, REBGV's chair, in a release.

Vancouver home sales up 73% year-over-year: REBGV

Churches challenge B.C. COVID-19 health orders

Henry and the province have said they are confident the health orders are in accordance with the law, including the Charter of Rights and Freedoms.

Churches challenge B.C. COVID-19 health orders

1478 COVID19 cases over 3 days

With the additional supply from the newly approved AstraZeneca/Serum Institute of India viral vector vaccine, combined with setting the second dose interval at 16 weeks, everyone moves up the line, meaning more people will be vaccinated more quickly.

1478 COVID19 cases over 3 days

AstraZeneca's vaccine not for seniors: NACI

The AstraZeneca vaccine was authorized for use Friday on all adults, including seniors, but the National Advisory Committee on Immunization is concerned there is limited data on how well the vaccine will work in older populations.